Let Me Tell You More About My Depressed, Miserable Existence
By Depressed Jane on May 8, 2008
Forest Laboratories, Inc. (NYSE: FRX) announced that study results show Lexapro (escitalopram oxalate) significantly improved symptoms of depression as compared to placebo treatment and was well tolerated in adolescents, aged 12-17, with major depressive disorder (MDD), according to phase III data presented at the 2008 Annual Meeting of the American Psychiatric Association.
Popularity: unranked [?]
By Depressed Jane on May 7, 2008
A new revision of clinical guidelines to help doctors manage patients with depression has challenged the rationale behind the UK government’s policy of rolling out of cognitive behavioural therapy (CBT) for milder depression.According to a comprehensive review of treatments for depression, there is a lack of evidence for CBT being more helpful than other forms of psychological support in mild depression or for its efficacy in severe depression.
Popularity: unranked [?]
The Journal of Environmental and Occupational Medicine (JOEM) has published a series of new studies that suggest depression in the workplace may be a much bigger problem – with more serious social and economic impacts – than employers realize. The peer-reviewed journal has devoted an entire special-edition, titled “Depression in the Workplace,” to the topic, with 15 papers prepared by experts on depression and workplace health.
Popularity: unranked [?]
By Depressed Jane on May 7, 2008
Aspect Medical Systems, Inc. (NASDAQ: ASPM) will present study results from the BRITE (Biomarkers for Rapid Identification of Treatment Effectiveness) trial in major depression at the Society of Biological Psychiatry and American Psychiatric Association Annual Meetings in Washington D.C. this week.
Popularity: unranked [?]
By Depressed Jane on May 7, 2008
St. Jude Medical, Inc. (NYSE:STJ) announced pilot study results from the first multi-center study investigating deep brain stimulation (DBS) of Brodmann Area 25 for major depressive disorder. Results of the study, which were presented at the American Psychiatric Association (APA) meeting in Washington, D.C., found that 6 months after the procedure, 56 percent of the patients experienced at least a 40 percent decrease in depressive symptoms.
Popularity: unranked [?]
By Depressed Jane on May 6, 2008
1. Selective serotonin reuptake inhibitors confirmed as treatment for depressionIn treating depression, a 6 to 9 month course of selective serotonin reuptake inhibitors following initial recovery after a first episode of depression is confirmed by this study. This systematic review, based on six classic long-term randomized controlled trials, supports current clinical practice guidelines.
Popularity: unranked [?]
AstraZeneca (NYSE:AZN) announced new study data on SEROQUEL XR™ (quetiapine fumarate) Extended-Release Tablets (quetiapine XR) for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD) in adult patients. The results from the studies were presented today at the 161st Annual Meeting of the American Psychiatric Association (APA) in Washington, DC.
Popularity: unranked [?]
By Depressed Jane on May 6, 2008
The children of parents who die suddenly – whether by suicide, accident or natural causes – are three times more likely to develop depression and are at higher risk for post-traumatic stress disorder (PTSD) than children who don’t face such a difficult life event, according to a University of Pittsburgh School of Medicine study published in the current issue of the Archives of Pediatric & Adolescent Medicine, one of the JAMA/Archives journals.
Popularity: 1% [?]
By Depressed Jane on May 6, 2008
Older adults with low blood levels of vitamin D and high blood levels of a hormone secreted by the parathyroid glands may have a higher risk of depression, according to a report in the May issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Popularity: unranked [?]
By Depressed Jane on May 5, 2008
People with recurrent depression have high rates of many common physical illnesses, such as gastric ulcer, rhinitis/hay fever, osteoarthritis, thyroid disease, hypertension and asthma, a new study has found. Published in the May 2008 issue of the British Journal of Psychiatry, the study compared 1546 people with recurrent depression with 884 psychiatrically healthy controls in terms of past treatment for 16 different physical disorders.
Popularity: 1% [?]
